e-learning
resources
Madrid 2019
Monday, 30.09.2019
Clinical aspects of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Microbiome landscape and disease duration role in allergy in adult patients with bronchiectasis
K. Gashynova (Dnipro, Ukraine), K. Suska (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine)
Source:
International Congress 2019 – Clinical aspects of airway diseases
Session:
Clinical aspects of airway diseases
Session type:
Thematic Poster
Number:
2763
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Gashynova (Dnipro, Ukraine), K. Suska (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine). Microbiome landscape and disease duration role in allergy in adult patients with bronchiectasis. 2763
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Evolution and prognosis of patients with Asthma or COPD hospitalized by COVID-19 infection. Diferences between them and the patients without airway pathology.
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Natural history of disease burden for US patients with asthma vs asthma and COPD
Source: Virtual Congress 2020 – Risk factors for chronic lung diseases
Year: 2020
Clinical course of childhood asthma: a role of disease severity
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008
The role of obesity in patients with sarcoidosis
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
Asthma and allergic diseases in patients with Behçet‘s disease
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
Effect of allergic sensitization on clinical course of patients with COPD in the Hokkaido COPD cohort study
Source: International Congress 2014 – COPD physiopathology
Year: 2014
The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016
Asthma control in subjects with persistent symptoms: a role of the disease severity
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008
Occurrence and impact of bronchiectasis in patients with COPD
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Early origins of chronic pulmonary disease: the role of the adult pulmonologist
Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine
Year: 2020
The effect of regional differences on visual arts interpretation in exacerbation and stable periods of chronic airway diseases
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Coeliac disease and asthma association in children: the role of antibiotic consumption
Source: Eur Respir J 2015; 46: 115-122
Year: 2015
Assessment of a disease management program for patients with asthma or COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 19s
Year: 2005
The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Systemic effects in patients with chronic obstructive pulmonary disease: a role of disease duration and disease severity
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014
Role of colonization on inflammation in COPD patients with bronchiectasis
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept